AmerisourceBergen Corporation (NYSE:ABC) agreed to acquire Pharmalex Holding Gmbh from AUCTUS Capital Partners AG for $1.5 billion on September 12, 2022. The transaction is expected to close by March 2023 and is subject to the satisfaction of customary closing conditions, including receipt of required regulatory approvals. Upon closing, the acquisition of PharmaLex is expected to be approximately $0.15 accretive to AmerisourceBergen’s adjusted diluted EPS (a non-GAAP financial measure defined herein) for the last seven months of its fiscal year 2023, which would contribute to AmerisourceBergen’s previously disclosed fiscal year 2023 growth target from capital deployment. Evercore is serving as financial advisor, and Freshfields Bruckhaus Deringer LLP and Sidley Austin LLP are serving as legal advisors to AmerisourceBergen. Paul Hepper, Julian Feneley, Cheairs Porter, Stephan Doering, Christopher Duerolf of Harris Williams is serving as financial advisor, and emnay Rechtsanwaltskanzlei and Noerr Partnerschaftsgesellschaft mbB are serving as legal advisors to AUCTUS/PharmaLex. Stephan Rau, Germar Enders, Nadine Hartung, Deniz Tschammler, Monika Richter, Jana Grieb, Gudrun Germakowski, Steffen Woitz, Sylvia Petereit-Kemter, Lea Hachmeister, Markus Cejka, Ilva Woeste, Sharon Lamb and Diego Gómez-Cornejo of McDermott Will & Emery acted as legal advisors to PharmaLex and AUCTUS. Spencer Klein of Morrison Foerster advised Evercore in its role as financial advisor to AmerisourceBergen Corporation .

AmerisourceBergen Corporation (NYSE:ABC) completed the acquisition of Pharmalex Holding Gmbh from AUCTUS Capital Partners AG on January 1, 2023.